PHGDH and lung cancer: High PHGDH expression has also been reported as a poor prognostic factor in patients with advanced or recurrent non‐small cell lung cancer treated with anti‐PD‐1/PD‐L1 antibodies, which would suggest that PHGDH inhibitors have potential clinical application [38].